| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 1396821 | European Journal of Medicinal Chemistry | 2009 | 7 Pages |
Abstract
The compound 1-(4-di-hydroxy-3,5-dioxa-4-borabicyclo[4.4.0]deca-7,9,11-trien-9-yl)-2-(tert-butylamino)ethanol shows greater affinity and intrinsic efficacy than salbutamol and acts as an agonist on the β2 adrenoceptor.
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
![Synthesis, pharmacological and in silico evaluation of 1-(4-di-hydroxy-3,5-dioxa-4-borabicyclo[4.4.0]deca-7,9,11-trien-9-yl)-2-(tert-butylamino)ethanol, a compound designed to act as a β2 adrenoceptor agonist](/preview/png/1396821.png "First Page Preview: Synthesis, pharmacological and in silico evaluation of 1-(4-di-hydroxy-3,5-dioxa-4-borabicyclo[4.4.0]deca-7,9,11-trien-9-yl)-2-(tert-butylamino)ethanol, a compound designed to act as a β2 adrenoceptor agonist")
Authors
Marvin A. Soriano-Ursúa, Ignacio Valencia-Hernández, Mónica G. Arellano-Mendoza, José Correa-Basurto, José G. Trujillo-Ferrara,